Pcn269 - Healthcare Resource Use (Hru) Associated With Treatment in Adults With Philadelphia Chromosome-Positive (Ph+) Relapsed or Refractory (R/R) B-Cell Precursor (Bcp) Acute Lymphoblastic Leukemia (All) in Eu-4 Countries

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.351
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Therapy With Imatinib Mesylate (Glivec) Preceding Allogeneic Stem Cell Transplantation (SCT) in Relapsed or Refractory Philadelphia-Positive Acute Lymphoblastic Leukemia (Ph+ALL)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2002English

Outcomes of Hematopoietic Stem Cell Transplantation (HSCT) Among Adults With Relapsed/Refractory (R/R) Acute Lymphoblastic Leukemia (ALL) Achieving Remission With Blinatumomab

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Pcn142 - Cost-Effectiveness Analysis of Inotuzumab Ozogamicin for the Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn71 - Budget Impact Analysis of Inotuzumab Ozogamicin for the Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Bulgaria

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn77 - Budget Impact Analysis of Blinatumomab for the Treatment of Pediatric Patients With Philadelphia Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in Mexico

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Effective Re-Induction Therapy With Dasatinib and Clofarabine in Relapsed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

Drugs and Therapy Studies
2012English

A Novel BCR-ABL1 Mutation in a Patient With Philadelphia Chromosome-Positive B-Cell Acute Lymphoblastic Leukemia

OncoTargets and Therapy
OncologyPharmacology
2018English

Impact of IKZF1 Deletions on IKZF1 Expression and Outcome in Philadelphia Chromosome Negative Childhood BCP-ALL. Reply to "Incidence and Biological Significance of IKZF1/Ikaros Gene Deletions in Pediatric Philadelphia Chromosome Negative and Philadelphia Chromosome Positive B-Cell Precursor Acute Lymphoblastic Leukemia"

Haematologica
Hematology
2013English

Current Paradigms in the Management of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia in Adults

American Journal of Hematology
Hematology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy